SEARCH

Current Edition

Akebia

FDA rejects Akebia drug, dealing another blow to anemia pills

Dive Brief: The Food and Drug Administration rejected an Akebia Therapeutics’ anemia pill vadadustat, the company announced Wednesday, over concerns the drug isn’t as safe as currently …

Continue Reading →
anemia

FibroGen cuts jobs as it weighs anemia drug’s future in US

The upcoming FDA meeting is critical for FibroGen. CEO Enrique Conterno told analysts on a conference call this week that he believes the company has …

Continue Reading →